Monday, October 7, 2024

HomeScience NewsExperimental mRNA cancer vaccine shows potential for advanced stage cancer patients in...

Experimental mRNA cancer vaccine shows potential for advanced stage cancer patients in Phase 1 trial

- Advertisement -


Interim data from the Phase I dose escalation part of the mRNA cancer immunotherapy (mRNA-4359), show promise in patients with advanced solid cancers.

The investigational mRNA cancer immunotherapy is targeted for patients with lung cancer, melanoma and other solid tumours. Nineteen patients with…



Click here to view the original article.

- Advertisment -

Recently Viewed